Fri-27-01-2017, 18:39 PM
(Fri-27-01-2017, 12:51 PM)jiml Wrote:(Fri-27-01-2017, 12:39 PM)Bill Wrote: Yes, fine now Jim, although I will probably check it in a week or two and make sure the tensioner is still set correctly. Personally I think that Biogen should be forking out for the MRI scans. The data collected will give a better determination of the safety of DMF, so it just looks like free research being done for Biogen.
Cheers,
Bill
I agree Bill they produce a drug. Charge a high price for it and health services around the world pick up the monitoring bill..... but poor cash strapped Biogen can't afford that
I was just reading that their projected turnover for the MS. Drug will be over 4 billion for this one drug, for this year alone ..... not bad when the raw product is extremely cheap
And the production of exactly the same medicine over with us is 20 times as cheap.
The price has been made because it should be in line with the other treatments for MS, if suddenly a cheap medication would be available then the other really more expensive medications would hardly be used anymore.
You are really in trouble if you have MS.